Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 24, 2026 08:45 ET | Source: Bernstein Liebhard LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aquestive Therapeutics, Inc. (AQST)

Aquestive Shareholders Between June 16, 2025 and January 8, 2026 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
March 19, 2026 16:09 ET | Source: The Rosen Law Firm PA

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AQST

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aquestive Therapeutics, Inc. (NASDAQ: AQST) between June...
March 19, 2026 09:00 ET | Source: Portnoy Law

Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors

LOS ANGELES, March 19, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Aquestive Therapeutics, Inc., (“Aquestive” or the "Company") (NASDAQ: AQST) investors off a class action on behalf of...
March 19, 2026 08:11 ET | Source: Bernstein Liebhard LLP

AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aquestive Therapeutics, Inc. Investors of Upcoming Deadline

Aquestive Shareholders Between June 16, 2025 and January 8, 2026 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
March 18, 2026 13:28 ET | Source: Faruqi & Faruqi LLP

AQST CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics Investors of Securities Class Action Deadline on May 4, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Aquestive To Contact Him Directly To Discuss Their Options If you purchased or...
March 17, 2026 08:18 ET | Source: Bernstein Liebhard LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aquestive Therapeutics, Inc. (AQST)

Aquestive Shareholders Between June 16, 2025 and January 8, 2026 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
March 16, 2026 18:10 ET | Source: The Rosen Law Firm PA

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AQST

NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Aquestive...
March 14, 2026 06:50 ET | Source: Faruqi & Faruqi LLP

AQST UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Aquestive To Contact Him Directly To Discuss Their Options If you purchased or...
March 12, 2026 08:24 ET | Source: Bernstein Liebhard LLP

AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aquestive Therapeutics, Inc. Investors of Upcoming Deadline

Aquestive Shareholders Between June 16, 2025 and January 8, 2026 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
March 11, 2026 19:01 ET | Source: Portnoy Law

Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors

LOS ANGELES, March 11, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Aquestive Therapeutics, Inc., (“Aquestive” or the "Company") (NASDAQ: AQST) investors off a class action on behalf of...